A study to test how different doses of BI 1015550 are taken up inthe body of healthy Japanese me
- Conditions
- ot applicable
- Registration Number
- JPRN-jRCT2071230092
- Lead Sponsor
- Mochizuki Toko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 12
Healthy male subjects, age of 18 to 45 years (inclusive), body mass index (BMI)
of 18.5 to 25.0 kg/m2 (inclusive)
-Any finding in the medical examination (including BP, PR, RR or ECG) deviating from
normal and assessed as clinically relevant by the investigator
-Repeated measurement of systolic blood pressure outside the range of 90 to 140 mmHg,
diastolic blood pressure outside the range of 40 to 90 mmHg, or PR outside the range of
40 to 99 bpm
-Any laboratory value outside the reference range that the investigator considers to be of
clinical relevance
-Any evidence of a concomitant disease assessed as clinically relevant by the investigator
-Any documented active or suspected malignancy or history of malignancy within 5 years
prior to screening, except appropriately treated basal cell carcinoma or in situ squamous
cell carcinoma of the skin or in situ carcinoma of uterine cervix
-Inability to comply with the dietary regimen of the trial site
-A marked prolongation of QT/QTc interval (such as QTc intervals that are repeatedly
greater than 450 ms in male) or any other relevant ECG finding at screening.
-A history of additional risk factors for Torsade de Pointes (such as heart failure,
hypokalaemia, or family history of Long QT Syndrome)
-Any lifetime history of suicidal behavior (i.e. actual attempt, interrupted attempt, aborted
attempt, or preparatory acts or behavior)
-History of vasculitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.